Tobias Welte, ERS 2020 – COVID-19 Vaccines and Early Trials
Access all of the content
It was a pleasure to meet with Prof. Tobias Welte (Medizinische Hochschule, Hannover, Germany), following his keynote presentation, to continue the discussion around COVID-19 management, current vaccine approaches and promising agents in clinical development.
1. What are the major obstacles to be overcome in the investigation of management and preventative strategies for COVID-19? (0:37)
2. In your opinion, what are the most promising agents in clinical development for COVID-19 treatment? (2:47)
3. What progress has been made in the development of monoclonal antibody therapies? (5:14)
4. Could you give us a brief overview of the status of the major vaccine trials worldwide? (6:18)
5. What have we learned in terms of improving the efficiency of vaccine studies? (9:23)
Speaker disclosure: Tobias Welte has received research grants from the DFG, BMBF, EU, and WHO. He has also received lecture fees from AstraZeneca, Basilea, Biotest, Bayer, Boehringer, Berlin Chemie GSK, Infectopharm, MSD, Novartis, Pfizer, Roche and acted as an advisory board member for AstraZeneca, Basilea, Biotest, Bayer, Boehringer, Gilead, GSK, Janssens, Novartis, Pfizer and Roche.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020.
Share this Video
Related Videos In COVID-19
Margaret Pisani, Research highlights in COVID-19 from 2022
Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this area. Disclosures: Margaret Pisani has nothing to disclose in relation to this video interview. Support: Interview and filming […]
Alan Kaplan: IPCRG COVID-19 and Respiratory Q&A – COVID-19 Controversies, Vaccination and Booster Doses
The IPCRG COVID-19 and Respiratory Q&A is providing evidence based COVID and respiratory advice to practising primary care clinicians. Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) answers questions from the Q&A on managing COVID-19, how to address the controversies surrounding the COVID-19 vaccines, and the immunity provided from COVID-19 vaccination and booster doses. […]
Fiona Mosgrove: IPCRG COVID-19 and Respiratory Q&A – a Focus on COVID-19
touchRESPIRATORY caught up with Dr Fiona Mosgrove (University of Aberdeen Medical School, Aberdeen, Scotland) to discuss the COVID-19 and respiratory Q&A created by IPCRG and to answer some of the key questions around the variants of SARS-CoV-2, treatments for COVID-19 and what will happen as we move out of the pandemic. Questions Could you give […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!